Your browser doesn't support javascript.
loading
Recognition of the toxicity of aristolochic acid.
Zhang, Hong-Mei; Zhao, Xiao-Hu; Sun, Zhi-Hui; Li, Gui-Chen; Liu, Guang-Chen; Sun, Li-Rui; Hou, Ji-Qiu; Zhou, Wei.
Afiliação
  • Zhang HM; Department of Pharmacy, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Zhao XH; Jilin Provincial Institute for Drug Control, Changchun, Jilin, China.
  • Sun ZH; Department of Pharmacy, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Li GC; Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Liu GC; Department of Orthopaedic Trauma, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Sun LR; Department of Pharmacy, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Hou JQ; Department of Pharmacy, The Second Hospital of Jilin University, Changchun, Jilin, China.
  • Zhou W; Department of Pharmacy, The First Hospital of Jilin University, Changchun, Jilin, China.
J Clin Pharm Ther ; 44(2): 157-162, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30548302
WHAT IS KNOWN AND OBJECTIVE: Aristolochic acid (AA) is an abundant compound in Aristolochia plants and various natural herbs. In the 1990s, a slimming formula used in Belgium that contains Aristolochia fangchi was reported to cause kidney damage and bladder cancer, and aristolochic acid nephropathy (AAN) is now well recognized worldwide. In October 2017, researchers reported an AA signature that is closely associated with hepatocellular carcinoma (HCC) worldwide. COMMENT: There are differing opinions on the toxicity of AA, and different countries have taken different measures to address the issue. There is a lack of clarity on the causal role of AA in hepatocarcinogenesis and on the potential underlying mechanisms for the reported nephrotoxicity and carcinogenicity. The toxicity of AA differs depending on gender and age, and other risk factors that could explain the variability in the toxicity of AA remain to be identified. WHAT IS NEW AND CONCLUSION: Whether preparations containing AA, such as many Chinese medicines, should be used remains controversial, and this issue warrants further investigation before definite conclusions can be drawn.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ácidos Aristolóquicos / Nefropatias / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Clin Pharm Ther Assunto da revista: FARMACIA / TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ácidos Aristolóquicos / Nefropatias / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Clin Pharm Ther Assunto da revista: FARMACIA / TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido